Effects of Adjunctive Lacosamide on Mood States and Quality of Life (QOL) in Patients With Epilepsy
NCT01296880 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2015-12-24
Summary
The purpose of this study is to determine the effect of lacosamide on mood and quality of life in people with epilepsy.
Conditions
Sponsors & Collaborators
-
UCB Pharma
collaborator INDUSTRY -
State University of New York - Downstate Medical Center
lead OTHER
Principal Investigators
-
Arthur C Grant, MD, PhD · State University of New York - Downstate Medical Center
Eligibility
- Min Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-06-30
- Primary Completion
- 2014-07-31
- Completion
- 2014-07-31
Countries
- United States
Study Locations
More Related Trials
-
Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures
NCT00655486 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures
NCT02408549 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset Seizures
NCT01832038 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Retrospective Study of Effectivity and Tolerability in Patients With Lacosamide Medication
NCT01858870 ·Status: COMPLETED
-
A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications
NCT02408523 ·Status: COMPLETED ·Phase: PHASE3
-
Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy
NCT01118962 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children.
NCT02710890 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset Seizures
NCT01710657 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ≥1 Month to <4 Years With Partial-onset Seizures
NCT02477839 ·Status: COMPLETED ·Phase: PHASE3
-
Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures
NCT00655551 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures.
NCT01969851 ·Status: COMPLETED ·Phase: PHASE2
-
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures
NCT00520741 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-Label Study to Determine Safety , Tolerability, and Efficacy of Oral Lacosamide in Children With Epilepsy
NCT00938912 ·Status: COMPLETED ·Phase: PHASE2
-
Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures
NCT00522275 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study to Investigate the Long-term Use of Lacosamide as Monotherapy in Subjects Who Completed Study SP0994
NCT02582866 ·Status: COMPLETED ·Phase: PHASE3
-
Lacosamide Intravenous Injection for Emergency Termination of Status Epilepticus
NCT06966830 ·Status: NOT_YET_RECRUITING
-
Lacosamide in Preventing Seizures in Participants With Malignant Glioma
NCT01432171 ·Status: TERMINATED ·Phase: NA
-
Compassionate Use Program With Lacosamide in Patients With Partial-onset or Generalized Tonic-clonic Seizures
NCT03559673 ·Status: NO_LONGER_AVAILABLE
-
Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures
NCT00955357 ·Status: COMPLETED ·Phase: PHASE4
-
Crossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy Subjects
NCT01530022 ·Status: COMPLETED ·Phase: PHASE1
-
A Real World Study on the Efficacy and Safety of Lacosamide as Add-on Therapy for Focal-onset Epilepsy
NCT04737837 ·Status: UNKNOWN
-
A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures
NCT00938431 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Efficacy and Safety of Lacosamide in Pediatric Patients With Epilepsy
NCT04144218 ·Status: UNKNOWN ·Phase: PHASE4
-
Assess Safety and Efficacy of Lacosamide in Patients With Partial Seizures
NCT00515619 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Lacosamide as an Adjunctive Drug Treatment for Epilepsy in Patients With Brain Tumors
NCT02276053 ·Status: COMPLETED